The series is stated in the current share scale after splits; dividends are not included in the price
Stryker makes orthopaedic implants and surgical instruments — its revenue follows the number of procedures.
The main lines are joint replacements, neurosurgical and trauma instruments, hospital beds and equipment. Demand is demographic: an ageing population produces steady growth in knee and hip replacements, largely independent of the economic cycle.
The key competitive advantage is a robotic platform for implant placement: a surgeon trained on it keeps using that company's implants, and a hospital that buys the system is locked in for years. That turns an equipment sale into a channel for consumables.
The constraint is hospital throughput and staffing: when nurses are short, procedures are postponed, and that shows in the accounts. The company also grows by acquiring specialist manufacturers. Stryker pays a dividend with a long record of increases.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
Stryker Corporation (SYK) is a company in the Health care sector; its shares trade on NYSE.
The price of Stryker Corporation (SYK) on November 2, 2026 is 298.07 $, +2.13 % on the day. Over 52 weeks the stock traded between 267.00 $ and 392.55 $; the price now sits 25 % of the way up that range. Over the past year the price changed by −20.70 %. The P/E ratio is 30.20, which is above the sector median (24.61). Market capitalization is 112.60 billion $, rank 1 among 100 stocks of the same industry with a known capitalization.
Stryker Corporation trades on NYSE under the ticker SYK. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks SYK has traded between 267.00 $ and 392.55 $. As of 2 November 2026 the price stood 20.89 % of the way from the 52-week low to the high.
Over one year SYK shares fell 20.70 %; over six months they fell 13.34 %. Volatility over 90 days is 38.50 %. Dividends are not included: this is price change only, as of 2 November 2026.
SYK trades at a price-to-earnings ratio of 30.2, above the sector median of 24.6. Price to sales is 4.4, above the sector median of 3.6. Price to book is 4.7, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Stryker Corporation reported revenue of 25.8B $ and net income of 3.7B $ over the last four quarters. Net margin is 14.43 %. Revenue changed by +8.48 % year over year. Earnings per share are 9.65 $. Market capitalisation is 112.6B $.
SYK has a return on equity of 15.55 %, above the sector median of −40.58 %. Return on assets is 7.78 %, above the sector median of −30.08 %. Operating margin is 21.42 %, above the sector median of −20.96 %.
